Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion

Cognitive impairment is a feature of many psychiatric diseases, including schizophrenia. Here we aim to identify multimodal biomarkers for quantifying and predicting cognitive performance in individuals with schizophrenia and healthy controls. A supervised learning strategy is used to guide three-wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Jing, Qi, Shile, van Erp, Theo G. M., Bustillo, Juan, Jiang, Rongtao, Lin, Dongdong, Turner, Jessica A., Damaraju, Eswar, Mayer, Andrew R., Cui, Yue, Fu, Zening, Du, Yuhui, Chen, Jiayu, Potkin, Steven G., Preda, Adrian, Mathalon, Daniel H., Ford, Judith M., Voyvodic, James, Mueller, Bryon A., Belger, Aysenil, McEwen, Sarah C., O’Leary, Daniel S., McMahon, Agnes, Jiang, Tianzi, Calhoun, Vince D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072778/
https://www.ncbi.nlm.nih.gov/pubmed/30072715
http://dx.doi.org/10.1038/s41467-018-05432-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072778/
https://www.ncbi.nlm.nih.gov/pubmed/30072715
http://dx.doi.org/10.1038/s41467-018-05432-w

Ejemplares similares